Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$206K Buy
629
+207
+49% +$65.7K 0.09% 61
2025
Q3
$119K Buy
422
+122
+41% +$35.4K 0.05% 70
2025
Q2
$83.9K Buy
300
+279
+1,329% +$79K 0.05% 75
2025
Q1
$6.55K Sell
21
-13
-38% -$3.84K ﹤0.01% 242
2024
Q4
$8.85K Buy
34
+22
+183% +$6.53K 0.01% 239
2024
Q3
$3.81K Hold
12
﹤0.01% 246
2024
Q2
$3.67K Buy
+12
New +$3.52K ﹤0.01% 256
2024
Q1
Sell
-12
Closed -$3.33K 83
2023
Q4
$3.33K Buy
12
+1
+9% +$272 ﹤0.01% 274
2023
Q3
$3.09K Hold
11
﹤0.01% 243
2023
Q2
$2.53K Sell
11
-5
-31% -$1.16K ﹤0.01% 272
2023
Q1
$3.78K Buy
16
+1
+7% +$245 ﹤0.01% 254
2022
Q4
$4.07K Hold
15
﹤0.01% 258
2022
Q3
$4K Hold
15
﹤0.01% 244
2022
Q2
$4K Buy
+15
New +$3.68K ﹤0.01% 241

Other funds holding AMGN

New Millennium Group's AMGN Position: Q4 2025 in Review

New Millennium Group increased its Amgen (AMGN) stake by 49% in Q4 2025, buying an estimated $65.7K and bringing the position to 629 shares worth $206K. The position accounts for 0.09% of the portfolio, ranked #61.

New Millennium Group first reported a position in AMGN in Q2 2022 and has held it in 14 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • New Millennium Group held 629 shares of Amgen worth $206K as of Q4 2025.
  • New Millennium Group bought 207 Amgen shares in Q4 2025, an estimated $65.7K.
  • Amgen made up 0.09% of New Millennium Group's portfolio in Q4 2025, its #61 holding.
  • New Millennium Group first reported a position in Amgen in Q2 2022 and has held it in 14 quarters since.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.